Price$56.94+1.27 (+2.28%)
01:30 PM07:45 PM
News · 26 weeks54-100%
2026-04-192026-10-11
Mix2390d
- SEC Filings11(48%)
- Insider8(35%)
- Other4(17%)
Latest news
25 items- INSIDERChief Executive Officer Quisel John D exercised 36,000 shares at a strike of $1.01, increasing direct ownership by 16% to 262,064 units (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- INSIDERDirector Bitterman Kevin exercised 27,136 shares at a strike of $45.07 and sold $1,902,505 worth of shares (27,136 units at $70.11) (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
- SECDisc Medicine Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Disc Medicine, Inc. (0001816736) (Filer)
- INSIDERDirector Bitterman Kevin sold $135,052 worth of shares (1,689 units at $79.96) as part of a pre-agreed trading plan (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- INSIDERDirector Bitterman Kevin sold $4,367,944 worth of shares (54,496 units at $80.15) as part of a pre-agreed trading plan (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
- PRDisc Medicine to Participate in Upcoming Investor ConferencesWATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences: Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 9th at 8:35 a.m. ET in New York, NY.Wells Fargo 21st Annual Healthcare Conference on Thursday, September 10th at 8:00 a.m. ET in Everett, MA.Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th at 10:45 a.m. ET in
- PRDisc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual MeetingWATERTOWN, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple clinical programs, including an oral presentation of initial data from the RESTORE-PV trial of DISC-3405 in patients with polycythemia vera (PV), at the SOHO Annual Meeting, which will be held in Houston, Texas on September 9-12, 2026. "We are excited to share the first clinical data from our Phase 2 study of DISC-3405 in polycythemia vera at the upcoming SOHO conferenc
- INSIDERChief Operating Officer Yu Jonathan Yen-Wen exercised 9,096 shares at a strike of $13.50 and sold $755,852 worth of shares (9,096 units at $83.10) as part of a pre-agreed trading plan (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- INSIDERChief Executive Officer Quisel John D exercised 33,000 shares at a strike of $13.50 and sold $2,611,982 worth of shares (33,000 units at $79.15) as part of a pre-agreed trading plan (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
- INSIDERChief Operating Officer Yu Jonathan Yen-Wen exercised 804 shares at a strike of $13.50 and sold $66,445 worth of shares (804 units at $82.64) as part of a pre-agreed trading plan (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- INSIDERChief Legal Officer Khara Rahul exercised 5,000 shares at a strike of $14.69 and sold $400,000 worth of shares (5,000 units at $80.00) as part of a pre-agreed trading plan (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Disc Medicine Inc.SCHEDULE 13G/A - Disc Medicine, Inc. (0001816736) (Subject)
- SECSEC Form 10-Q filed by Disc Medicine Inc.10-Q - Disc Medicine, Inc. (0001816736) (Filer)
- SECDisc Medicine Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Disc Medicine, Inc. (0001816736) (Filer)
- PRDisc Medicine Reports Second Quarter 2026 Financial Results and Provides Business UpdateCompleted Type A meeting with the FDA on bitopertin and aligned that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response; topline data expected in Q4 2026Launched Expanded Access Program (EAP) for bitopertin for eligible erythropoietic protoporphyria (EPP) patientsPresented positive clinical data updates from the RALLY-MF Phase 2 trial of selcodebart (DISC-0974) in anemia of myelofibrosis and the HELIOS open-label extension trial of bitopertin in EPPCompleted enrollment for RESTORE-PV Phase 2 study of DISC-3405 in polycythemia vera (PV) with initial data expected in Q3 2026 and progressing Phase 1b study of DISC-3405 in sickle cell disease (SCD) with initial data
- INSIDERChief Executive Officer Quisel John D exercised 33,000 shares at a strike of $10.68 and sold $2,473,780 worth of shares (33,000 units at $74.96) as part of a pre-agreed trading plan (SEC Form 4)4 - Disc Medicine, Inc. (0001816736) (Issuer)
- SECSEC Form 144 filed by Disc Medicine Inc.144 - Disc Medicine, Inc. (0001816736) (Subject)
IRON FAQ
5 questionsWhere does IRON stock trade?
Disc Medicine Inc. (IRON) is listed on NASDAQ.What sector and industry is IRON in?
Disc Medicine Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about IRON?
Disc Medicine Inc. has had 8 recent analyst actions on file. The most recent action was from Stifel: Buy on 2025-11-03.What companies are similar to IRON?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare IRON side-by-side with any of them on Quantisnow.How can I track IRON on Quantisnow?
Quantisnow aggregates Disc Medicine Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IRON to receive live email and push alerts on every new disclosure.